Literature DB >> 18775727

Insights into the catalytic mechanism of human sEH phosphatase by site-directed mutagenesis and LC-MS/MS analysis.

Annette Cronin1, Shirli Homburg, Heike Dürk, Ingrid Richter, Magdalena Adamska, Frederic Frère, Michael Arand.   

Abstract

We have recently reported that human soluble epoxide hydrolase (sEH) is a bifunctional enzyme with a novel phosphatase enzymatic activity. Based on a structural relationship with other members of the haloacid dehalogenase superfamily, the sEH N-terminal phosphatase domain revealed four conserved sequence motifs, including the proposed catalytic nucleophile D9, and several other residues potentially implicated in substrate turnover and/or Mg(2+) binding. To enlighten the catalytic mechanism of dephosphorylation, we constructed sEH phosphatase active-site mutants by site-directed mutagenesis. A total of 18 mutants were constructed and recombinantly expressed in Escherichia coli as soluble proteins, purified to homogeneity and subsequently analysed for their kinetic parameters. A replacement of residues D9, K160, D184 or N189 resulted in a complete loss of phosphatase activity, consistent with an essential function for catalysis. In contrast, a substitution of D11, T123, N124 and D185 leads to sEH mutant proteins with altered kinetic properties. We further provide evidence of the formation of an acylphosphate intermediate on D9 by liquid chromatography-tandem mass spectrometry based on the detection of homoserine after NaBH(4) reduction of the phosphorylated enzyme, which identifies D9 as the catalytic nucleophile. Surprisingly, we could only show such homoserine formation using the D11N mutant, which strongly suggests D11 to be involved in the acylphosphate hydrolysis. In the D11 mutant, the second catalytic step becomes rate limiting, which then allows trapping of the labile intermediate. Substrate turnover in the presence of (18)H(2)O revealed that the nucleophilic attack during the second reaction step occurs at the acylphosphate phosphorous. Based on these findings, we propose a two-step catalytic mechanism of dephosphorylation that involves the phosphate substrate hydrolysis by nucleophilic attack by the catalytic nucleophile D9 followed by hydrolysis of the acylphosphate enzyme intermediate supported by D11.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18775727     DOI: 10.1016/j.jmb.2008.08.049

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  6 in total

1.  Investigation of the binding mode of 1, 3, 4-oxadiazole derivatives as amide-based inhibitors for soluble epoxide hydrolase (sEH) by molecular docking and MM-GBSA.

Authors:  Leila Karami; Ali Akbar Saboury; Elham Rezaee; Sayyed Abbas Tabatabai
Journal:  Eur Biophys J       Date:  2016-12-07       Impact factor: 1.733

2.  Lysophosphatidic acids are new substrates for the phosphatase domain of soluble epoxide hydrolase.

Authors:  Ami Oguro; Susumu Imaoka
Journal:  J Lipid Res       Date:  2012-01-03       Impact factor: 5.922

3.  Mammalian soluble epoxide hydrolase is identical to liver hepoxilin hydrolase.

Authors:  Annette Cronin; Martina Decker; Michael Arand
Journal:  J Lipid Res       Date:  2011-01-07       Impact factor: 5.922

4.  An insect farnesyl phosphatase homologous to the N-terminal domain of soluble epoxide hydrolase.

Authors:  Li Cao; Ping Zhang; David F Grant
Journal:  Biochem Biophys Res Commun       Date:  2009-01-23       Impact factor: 3.575

5.  15-deoxy-Δ12,14-Prostaglandin J2 inhibits human soluble epoxide hydrolase by a dual orthosteric and allosteric mechanism.

Authors:  Giancarlo Abis; Rebecca L Charles; Jolanta Kopec; Wyatt W Yue; R Andrew Atkinson; Tam T T Bui; Steven Lynham; Simona Popova; Yin-Biao Sun; Franca Fraternali; Philip Eaton; Maria R Conte
Journal:  Commun Biol       Date:  2019-05-17

6.  Essential Functional Interplay of the Catalytic Groups in Acid Phosphatase.

Authors:  Martin Pfeiffer; Rory M Crean; Catia Moreira; Antonietta Parracino; Gustav Oberdorfer; Lothar Brecker; Friedrich Hammerschmidt; Shina Caroline Lynn Kamerlin; Bernd Nidetzky
Journal:  ACS Catal       Date:  2022-02-28       Impact factor: 13.084

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.